These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 27612633

  • 1. Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo.
    Tseng TH, Lin WL, Chen ZH, Lee YJ, Shie MS, Lee KF, Shen CH, Kuo HC.
    J Transl Med; 2016 Sep 09; 14(1):263. PubMed ID: 27612633
    [Abstract] [Full Text] [Related]

  • 2. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D, Zou J, Zhu X, Chen X, Luo J, Kong L, Zhang H.
    Phytomedicine; 2020 Nov 09; 78():153294. PubMed ID: 32771890
    [Abstract] [Full Text] [Related]

  • 3. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-β/Smad signaling pathway.
    Zou GL, Zuo S, Lu S, Hu RH, Lu YY, Yang J, Deng KS, Wu YT, Mu M, Zhu JJ, Zeng JZ, Zhang BF, Wu X, Zhao XK, Li HY.
    World J Gastroenterol; 2019 Aug 14; 25(30):4222-4234. PubMed ID: 31435175
    [Abstract] [Full Text] [Related]

  • 4. Sestrin 2 Attenuates Rat Hepatic Stellate Cell (HSC) Activation and Liver Fibrosis via an mTOR/AMPK-Dependent Mechanism.
    Hu YB, Ye XT, Zhou QQ, Fu RQ.
    Cell Physiol Biochem; 2018 Aug 14; 51(5):2111-2122. PubMed ID: 30522100
    [Abstract] [Full Text] [Related]

  • 5. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis.
    Kao YH, Lin YC, Tsai MS, Sun CK, Yuan SS, Chang CY, Jawan B, Lee PH.
    Biochim Biophys Acta; 2014 Sep 14; 1842(9):1720-32. PubMed ID: 24970745
    [Abstract] [Full Text] [Related]

  • 6. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
    Jiang Y, Wang C, Li YY, Wang XC, An JD, Wang YJ, Wang XJ.
    J Ethnopharmacol; 2014 Dec 02; 158 Pt A():230-8. PubMed ID: 25456431
    [Abstract] [Full Text] [Related]

  • 7. Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo.
    Wang Y, Zhang X, Yang Y, Yang X, Ye B.
    Mar Drugs; 2015 Aug 18; 13(8):5201-18. PubMed ID: 26295240
    [Abstract] [Full Text] [Related]

  • 8. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH, Kim SC, Kim KM, Jang CH, Cho SS, Kim SJ, Ku SK, Cho IJ, Ki SH.
    Eur J Pharmacol; 2016 Jul 15; 783():92-102. PubMed ID: 27151496
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing NF-κB signaling and Wnt/β-catenin signaling.
    Sun H, Chen G, Wen B, Sun J, An H, Pang J, Xu W, Yang X, He S.
    J Pharmacol Sci; 2018 Mar 15; 136(3):133-141. PubMed ID: 29501581
    [Abstract] [Full Text] [Related]

  • 12. Thymosin β4 suppresses CCl4 -induced murine hepatic fibrosis by down-regulating transforming growth factor β receptor-II.
    Li H, Li Q, Zhang X, Zheng X, Zhang Q, Hao Z.
    J Gene Med; 2018 Sep 15; 20(9):e3043. PubMed ID: 29972714
    [Abstract] [Full Text] [Related]

  • 13. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
    Choi YJ, Kim DH, Kim SJ, Kim J, Jeong SI, Chung CH, Yu KY, Kim SY.
    Life Sci; 2014 Jul 17; 108(2):94-103. PubMed ID: 24880074
    [Abstract] [Full Text] [Related]

  • 14. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
    Ma JQ, Sun YZ, Ming QL, Tian ZK, Yang HX, Liu CM.
    Int Immunopharmacol; 2019 Dec 17; 77():105984. PubMed ID: 31677501
    [Abstract] [Full Text] [Related]

  • 15. Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.
    Yi HS, Eun HS, Lee YS, Jung JY, Park SH, Park KG, Choi HS, Suh JM, Jeong WI.
    PLoS One; 2015 Dec 17; 10(5):e0127946. PubMed ID: 26024318
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cav-1 deficiency promotes liver fibrosis in carbon tetrachloride (CCl4)-induced mice by regulation of oxidative stress and inflammation responses.
    Ji DG, Zhang Y, Yao SM, Zhai XJ, Zhang LR, Zhang YZ, Li H.
    Biomed Pharmacother; 2018 Jun 17; 102():26-33. PubMed ID: 29549726
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
    Yu HX, Yao Y, Bu FT, Chen Y, Wu YT, Yang Y, Chen X, Zhu Y, Wang Q, Pan XY, Meng XM, Huang C, Li J.
    Mol Immunol; 2019 Mar 17; 107():29-40. PubMed ID: 30639476
    [Abstract] [Full Text] [Related]

  • 20. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
    He J, Bai K, Hong B, Zhang F, Zheng S.
    Int Immunopharmacol; 2017 Dec 17; 53():56-62. PubMed ID: 29035816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.